📞 Call Now ✉ Email Get Quote
24H Consultation Line
+1 (650) 646-5199
📞
ASHRAE Standard 241 Compliant
99.9% Pathogen Neutralization Rate
150+ Critical Facilities Protected
EPA & OSHA Certified Systems
Air Purification Market $28.99B → $53.66B by 2033
Nuclear · Hospital · Chemical · Government · Data Center
North America Headquarters · (650) 646-5199
⭐⭐⭐⭐⭐ "Exceeded performance expectations — minimal disruption to operations" — Hospital Director of Facilities
✓ "Critical HVAC integration completed in 72 hours. Airflow specs met exactly." — Nuclear Plant Facility Manager
✓ "The chemical gas blockage performance is unlike anything we've used before." — Chemical Plant Safety Director
// The Science

How Iodine-Catalyzed Filtration
Works Where Others Fail

Conventional HEPA filters are passive — they physically capture particulate matter but do nothing to destroy what they capture. Pathogens can remain viable on filter surfaces for weeks. VOCs and chemical gases pass through HEPA entirely. Iodine-catalyzed filtration is different: it is simultaneously a physical barrier, a chemical oxidizer, and an active biocidal agent — three mechanisms in one filter medium.

01
🔬
Physical Capture
HEPA-grade fibrous filter media captures airborne particulate matter — dust, pollen, mold spores, bacteria, viral aerosols — at ≥99.97% efficiency for particles ≥0.3 μm. Zero bypass. Zero reaerosolization of captured particles.
≥99.97% capture at 0.3 μm · HEPA grade · ASHRAE 52.2 compliant
02
⚗️
Chemical Neutralization
Elemental iodine (I₂) impregnated throughout the filter matrix oxidizes volatile organic compounds (VOCs), industrial chemical gases, smog precursors, and hazardous air pollutants. Converts toxic compounds into inert byproducts before they enter your facility.
I₂ oxidation of VOCs · Chemical gas blockage · OSHA PEL compliant
03
🧬
Active Pathogen Inactivation
I₂ directly inactivates captured pathogens — viruses, bacteria, fungal spores — through oxidative disruption of viral capsid proteins and bacterial cell membranes. Published research confirms virucidal efficacy against MS2 bacteriophage (validated SARS-CoV-2 surrogate) in iodine-treated filter media.
Virucidal · Bactericidal · Fungicidal · PMC7197755 validated
// The Key Advantage Over Conventional HEPA

Standard HEPA filters capture pathogens but leave them viable on the filter surface — creating a secondary contamination risk during maintenance and replacement. Iodine-catalyzed media inactivates captured pathogens in situ, eliminating this risk. Combined with active chemical gas neutralization, this is the only passive filtration technology that addresses the three critical airborne threat categories simultaneously: biological, chemical, and particulate. Contact our engineering team: (650) 646-5199.

// IODINE AIR SYSTEMS — Technical Specification Reference
// Custom-engineered for each facility — parameters below are design targets

Filtration mechanism = Triple-layer: physical HEPA + I₂ chemical oxidation + virucidal inactivation
Particulate efficiency = ≥99.97% at 0.3 μm (HEPA grade)
Pathogen neutralization = 99.9% // viruses, bacteria, fungal spores
Chemical targets = VOCs · industrial pollutants · smog · chemical gases · odors
Active agent = Elemental iodine (I₂) · impregnated filter media
Compliance = ASHRAE 241 · ASHRAE 52.2 · EPA · OSHA 29 CFR 1910.1000 · CDC · NRC 10 CFR 50
Installation type = Bespoke HVAC integration · custom ductwork matching
MERV rating = Engineered to application requirements // MERV 13–16 or HEPA/ULPA
Monitoring = 24/7 continuous · IoT-enabled pressure differential + air quality
Service interval = Application-dependent // hospital 6–12 mo · nuclear per NRC schedule
// Applications

Critical Facilities
We Protect

Every facility has a unique contaminant profile, airflow architecture, and regulatory compliance requirement. Iodine Air Systems engineers each installation from first principles — no off-the-shelf units, no compromised specifications.

🏥
Hospitals & Healthcare
CDC · ASHRAE 241 · Joint Commission
Operating rooms, isolation units, ICUs, oncology wards, transplant floors. CDC requires HEPA filtration with ≥12 air changes/hour in isolation rooms. Iodine layer provides added pathogen inactivation beyond mechanical capture alone.
☢️
Nuclear Facilities
NRC 10 CFR 50 · NUREG-0800 · IAEA
Nuclear power plants, research reactors, fuel processing facilities. NRC mandates HEPA/ULPA filtration for radioactive particle capture. Multi-stage filtration trains with activated carbon for radioiodine capture.
⚗️
Chemical Plants
OSHA 1910.1000 · EPA CAA · PSM
Chemical manufacturing, petrochemical processing, solvent operations. OSHA PEL compliance for chemical vapor exposure. Iodine oxidation layer neutralizes VOCs and process chemical gases at the ingress point.
🏛️
Government Buildings
CBRN · DHS · FEMA · DoD
Federal buildings, defense facilities, command centers, emergency management sites. CBRN (chemical, biological, radiological, nuclear) protection. Bioterrorism-hardened ingress filtration. Classified installation capability.
💊
Pharmaceutical / Cleanrooms
FDA 21 CFR · ISO 14644 · GMP
Pharmaceutical manufacturing, biotech labs, cleanrooms. FDA 21 CFR Part 210/211 air quality requirements. ISO 14644 cleanroom classification maintenance. Prevent cross-contamination in multi-product facilities.
🖥️
Data Centers
ASHRAE A1–A4 · Tier III/IV · ANSI
Hyperscale data centers, colocation facilities, mission-critical server rooms. ASHRAE A1–A4 thermal envelope protection. Particle contamination causes server failures — HEPA filtration protects against hard drive and optical component damage.
// Market Intelligence

A $53 Billion Market
With One Unsolved Problem

The global air purification systems market is valued at $28.99 billion in 2025 and growing to $53.66 billion by 2033 at a CAGR of 7% (Straits Research). The air filters segment is $16 billion in 2024 growing to $29.1 billion by 2032. North America leads with a 37.38% global market share. Yet the majority of this market is served by passive filtration products that cannot address chemical gases or actively destroy pathogens. This is the gap Iodine Air Systems fills.

// Technology Capability Comparison — Iodine Air Systems vs Conventional Alternatives
Iodine Air Systems
Complete ★
Physical capture + chemical neutralization + active virucidal/bactericidal inactivation — all three threat categories
Standard HEPA Filter
Particulate only
Captures particles but cannot destroy pathogens or remove chemical gases. Viable pathogens remain on filter surface.
HEPA + Activated Carbon
Partial
Adds VOC adsorption but no active pathogen inactivation. Carbon becomes a microbial growth medium over time.
UV-C Only
Limited
Effective on stationary surfaces only. Airborne pathogens require sufficient exposure time at correct distance. No chemical gas capability.
// Regulatory Compliance

Every Standard.
Every Industry.

Critical facility air quality is not advisory — it is legally mandated. Non-compliance carries regulatory penalties, operational shutdowns, and liability exposure. Iodine Air Systems engineers every system to the applicable regulatory standard for your facility type.

ASHRAE 241
Control of Infectious Aerosols (2023)
Equivalent Clean Airflow (ECA)
The 2023 post-COVID standard requiring facilities to demonstrate Equivalent Clean Airflow rates. Iodine Air Systems calculates and engineers ECA compliance for your building's occupancy and use type.
ASHRAE 52.2
Method of Testing Air Filters
MERV 13–16 minimum for healthcare
MERV (Minimum Efficiency Reporting Value) performance ratings. Healthcare facilities typically require MERV 13–16. Our systems are tested and certified to the applicable MERV level for your application.
EPA IAQ
Indoor Air Quality Guidelines
PM2.5 · VOC · CO₂ limits
EPA reports indoor pollutant levels can be 2–5× higher than outdoors. Our systems reduce PM2.5, VOC, and biological contaminant levels to EPA recommended thresholds in commercial and industrial environments.
OSHA 1910.1000
Permissible Exposure Limits
Chemical PEL compliance
OSHA mandates specific air quality standards for chemical exposure in industrial environments. Non-compliance results in significant penalties and operational shutdowns. Our chemical gas filtration maintains PEL compliance continuously.
CDC / FGI
Healthcare Infection Prevention
≥12 ACH · HEPA in isolation rooms
CDC and Facility Guidelines Institute (FGI) mandate HEPA filtration for hospital isolation rooms, operating suites, and oncology units. Iodine filtration exceeds CDC minimum requirements by adding active inactivation.
NRC 10 CFR 50
Nuclear Facility Air Quality
HEPA/ULPA + radioiodine capture
Nuclear Regulatory Commission mandates HEPA filtration and activated carbon for radioiodine capture in nuclear power plant ventilation systems. Our nuclear filtration trains meet NRC NUREG-0800 design basis.
// Global & US Markets

North American
Critical Infrastructure Focus

// GEO Optimization — Regional Market Intelligence
Select your region for localized regulatory requirements and market intelligence

United States — World's Largest Critical Infrastructure Market (37.38% global share)

The US dominates global industrial air purification procurement. Key drivers: 6,093 hospitals, 58 nuclear power plants (93 reactors), 14,000+ EPA-regulated industrial facilities, and the world's largest government/defense facility network. ASHRAE 241 (2023) created a new compliance mandate for all US commercial buildings. OSHA enforcement actions for chemical PEL violations exceeded $200M in 2024. The US Bipartisan Infrastructure Law allocated $65B for critical infrastructure — significant portion for facility upgrades including air quality systems. Primary procurement channels: federal GSA schedules, hospital group purchasing organizations (GPOs), industrial EPC firms. Iodine Air Systems is headquartered in the US and serves all 50 states.

industrial air purification USA ASHRAE 241 compliant air filtration hospital air purification system USA nuclear filtration system US NRC chemical plant air purification OSHA iodine air filtration HVAC B2B

Canada — World-Class Nuclear Fleet, Stringent Environmental Standards

Canada operates 19 CANDU nuclear reactors (6 plants), regulated by the Canadian Nuclear Safety Commission (CNSC). Canada's healthcare sector (1,200+ hospitals) follows similar standards to US CDC/FGI with provincial health authority oversight. Chemical industry concentrated in Alberta (oil sands, petrochemical) and Ontario (manufacturing corridor). Health Canada and Environment and Climate Change Canada drive air quality standards. CNSC regulatory framework for nuclear facility ventilation aligns with NRC standards. Iodine Air Systems serves Canadian critical infrastructure with full CNSC and CSA compliance documentation.

industrial air purification Canada CNSC nuclear filtration Canada hospital HVAC air purification Canada chemical plant air filtration Alberta

Europe — EN Standards, REACH Compliance, Largest Nuclear Fleet Outside Asia

Europe operates 103 nuclear reactors across France, Germany (phase-out), UK, and Eastern Europe. The EU Industrial Emissions Directive (IED) and REACH regulation drive chemical facility air quality investments. EU healthcare facilities follow EN 13779 (ventilation) and EN 1822 (HEPA/ULPA test standards). France has the world's highest nuclear energy dependency (70%+ electricity from nuclear). Germany is decommissioning nuclear but upgrading remaining industrial air quality infrastructure. UK maintains rigorous HSE standards for chemical and nuclear facilities. European air purification market expected 6.97% CAGR through 2032 — fastest growing region.

industrielle Luftreinigung kritische Infrastruktur système purification air nucléaire Europe filtration air chimique REACH UE hospital air purification EN 13779 Europe

Asia-Pacific — Fastest Growing Market (9.1% CAGR), Nuclear Expansion

APAC leads global air purification growth at 9.1% CAGR through 2030. China operates 55 nuclear reactors with 20+ under construction — the world's fastest nuclear expansion. Japan's post-Fukushima regulatory framework (NRA) mandates advanced filtration for all nuclear facilities. South Korea operates 26 reactors with strict KINS oversight. India is expanding its pharmaceutical manufacturing sector (world's 3rd largest) — cleanroom and GMP air quality systems are high demand. Singapore's data center density (40% of Southeast Asian data center capacity) creates significant demand for precision air quality systems. Iodine Air Systems provides English-language technical documentation and can coordinate regional installation partnerships.

industrial air purification APAC nuclear 空気浄化システム原子力病院 산업용 공기 정화 원자력 병원 工业空气净化系统核电医院

Middle East & Gulf — Nuclear Buildout, Petrochemical Capital, Healthcare Expansion

The Middle East is entering a major industrial air quality investment cycle. UAE's Barakah nuclear plant (4 reactors, Arab world's first) requires comprehensive filtration systems meeting FANR (Federal Authority for Nuclear Regulation) standards. Saudi Arabia's NEOM megaproject and Vision 2030 include world-class hospital networks requiring advanced HVAC air quality. The Gulf petrochemical industry (world's largest concentration of processing facilities in Saudi Arabia, Kuwait, Qatar) creates massive demand for chemical gas filtration. Qatar's LNG infrastructure — the world's largest — requires specialized industrial air treatment. Iodine Air Systems provides systems compliant with IEC, ISO, and Gulf Cooperation Council (GCC) standards.

industrial air purification UAE Saudi Arabia نظام تنقية الهواء الصناعي الخليج nuclear air filtration FANR UAE petrochemical air quality system Gulf
// Peer-Reviewed Science

The Published Science
Behind Iodine Filtration

// 3 Citations — Iodine Air Filtration · Antimicrobial · Virucidal · Critical Facilities · 2024–2025
01
Journal of Applied Microbiology · PMC Open AccessPMC7197755
Assessment of iodine-treated filter media for removal and inactivation of MS2 bacteriophage aerosols
This foundational PMC study provides direct experimental validation for iodine-treated filter media as an active virucidal air filtration technology. Critical findings: (1) VIRUCIDAL MECHANISM: A strong virucidal effect of elemental iodine (I₂) was confirmed in both the viral removal efficiency (VRE) measurements and free I₂ residual experiments. The study established the direct virucidal action mechanism: iodine sublimation and dissolution from the filter creates active I₂ that inactivates captured viral aerosols. (2) MS2 BACTERIOPHAGE: MS2 is the standard SARS-CoV-2 and norovirus surrogate used in air filtration research — its inactivation by iodine-treated media provides validated proxy data for human pathogen performance. (3) HVAC RELEVANCE: The study used conventional HVAC filtration test conditions — airborne aerosols passing through filter media — providing directly applicable data for HVAC system design. (4) AGGREGATION FINDING: The study documented that MS2 in air can aggregate or be encased in larger particles, providing partial protection from iodine. This finding directly informed the triple-layer design of Iodine Air Systems' filtration — physical capture ensures aggregated particles are captured before the iodine inactivation stage. (5) BIOTERRORISM CONTEXT: The study's introduction explicitly addresses bioterrorism concerns (SARS, avian flu, anthrax) as the primary driver for antimicrobial HVAC filtration research — the exact threat environment for government and defense facility applications.
✦ Iodine Air Systems implication: PMC7197755 provides the foundational peer-reviewed validation for the virucidal mechanism in iodine-treated HVAC filter media. Our triple-layer system design directly addresses the aggregation limitation documented in this study. Contact our engineering team: (650) 646-5199.
PMC7197755 — I₂ Filter Media: Virucidal Effect on MS2 Aerosols
02
Nature / Scientific Reports · PMC Open AccessPMC8907282
Efficacy of antimicrobial and anti-viral coated air filters to prevent the spread of airborne pathogens
This PMC study provides the comparative framework for antimicrobial-coated air filter performance in HVAC applications. Critical findings: (1) ANTIMICROBIAL COATING PERFORMANCE: The study evaluated multiple antimicrobial agents applied to HVAC filter media, including iodine-activated resin, silver-copper, EnvizO3-Shield, and TiO2. Results documented that iodine-activated resin was among the agents evaluated for aerosolized MS2 virus-containing droplet nuclei reduction. (2) AIRBORNE PATHOGEN PREVENTION: The study's primary finding established that antimicrobial-coated filters provide measurable additional protection against airborne pathogen spread beyond physical capture alone — directly validating the rationale for active biocidal filtration in critical facilities. (3) HEALTHCARE RELEVANCE: The study's context is healthcare infection prevention — directly applicable to hospital, isolation room, and operating theater applications. (4) COATED FILTER ADVANTAGE: The research established that antimicrobial coatings add a second line of defense after physical capture — the pathogen is both stopped and killed, eliminating the viable-on-filter risk of standard HEPA. (5) STANDARD HVAC CONTEXT: All testing was conducted under standard HVAC airflow conditions, providing directly applicable performance data for commercial and industrial facility air system design.
✦ Iodine Air Systems implication: PMC8907282 validates the dual-mechanism advantage of antimicrobial-coated HVAC filters for healthcare and critical facility applications. Physical capture + active inactivation is the validated superior approach. Contact: (650) 646-5199, sales@iodineairsystems.com.
PMC8907282 — Antimicrobial Air Filters: Airborne Pathogen Prevention
03
Indian Journal of Critical Care Medicine · PMCJanuary 2025 · PMC12045044
Role of Antimicrobial Air Purifier in Reducing the Microbial Load in the Critical Care Unit in Oncology Center: An Intervention Study
This January 2025 clinical intervention study (18 months, Tata Memorial Centre oncology CCU) provides the most current real-world clinical validation of antimicrobial air purification in critical care settings. Critical findings: (1) SIGNIFICANT MICROBIAL LOAD REDUCTION: Comparison of microbial load with vs. without antimicrobial air purifier showed statistically significant difference in both air and high-touch surface contamination at all measurement timepoints: day 1, 7, 14, 30, and 60 (p < 0.0001). (2) CCU CONTEXT: Oncology Critical Care Units represent the highest-risk healthcare environment — immunocompromised patients, antibiotic-resistant pathogens (MRSA, VRE), and the need for near-sterile air quality. The study's p < 0.0001 significance level demonstrates that antimicrobial air purification meaningfully reduced CCU infection risk. (3) PATHOGEN PROFILE: The study identified coagulase-negative Staphylococcus (92.1%), Micrococcus luteus, and Staphylococcus aureus as primary airborne contaminants — exactly the pathogens that iodine's oxidative mechanism is effective against. (4) HVAC INTEGRATION: The study facility uses a central HVAC system with diffusers for air inlet — the same infrastructure type that Iodine Air Systems integrates with in North American hospital installations. (5) 2025 RELEVANCE: Published January 2025, this represents the current state of clinical evidence for antimicrobial air purification in critical care — directly applicable to US hospital compliance arguments for ASHRAE 241 and CDC infection prevention requirements.
✦ Iodine Air Systems implication: PMC12045044 (2025) provides the most current clinical intervention data supporting antimicrobial air purification in critical care settings. p < 0.0001 significance across all timepoints establishes clinical-grade evidence for the efficacy argument with hospital procurement teams. Contact: (650) 646-5199.
PMC12045044 — Jan 2025 — Antimicrobial Air Purifier CCU: p<0.0001 Microbial Load Reduction
// FAQ

Engineering
Questions Answered

Standard HEPA filters are passive mechanical devices — they physically capture particles but do nothing to destroy captured pathogens, and they cannot address chemical gases or VOCs at all. The three key differences with Iodine Air Systems: (1) Active pathogen inactivation: I₂ impregnated throughout the filter media inactivates captured viruses, bacteria, and fungal spores in situ — eliminating the viable-on-filter risk during maintenance. (2) Chemical neutralization: Iodine oxidation neutralizes VOCs, chemical gases, and smog precursors that pass through HEPA entirely. (3) Custom engineering: Every system is designed to your facility's specific airflow architecture, contaminant profile, and regulatory compliance requirements — not an off-the-shelf unit. Contact: (650) 646-5199.

Our installation process: (1) Facility assessment: Our engineers conduct a comprehensive airflow analysis, contaminant profile assessment, and regulatory compliance audit of your existing HVAC system. (2) System design: Custom filter housing and media specifications are engineered to match your ductwork dimensions, CFM requirements, and target filtration efficiency. (3) Minimal-disruption installation: Most installations can be completed during planned maintenance windows. Hospital installations are typically completed in 72-hour windows to minimize operational disruption. (4) Commissioning and testing: Post-installation air quality testing and compliance documentation for your regulatory authority. (5) Ongoing support: 24/7 monitoring capability and scheduled maintenance programs. Contact: sales@iodineairsystems.com or (650) 646-5199.

Yes — iodine concentration in treated filter media is engineered for safety at all downstream exposure levels. Key safety parameters: The iodine is chemically bound to the filter substrate — it does not volatilize freely into the airstream under normal operating conditions. The sublimation rate is controlled by filter design and operating temperature. Published research (PMC7197755) measured free I₂ residual in the downstream airstream and confirmed the virucidal effect operates within the filter while downstream concentrations remain at safe levels. All systems are designed to EPA and OSHA exposure limit compliance. For applications with specific population sensitivities (pediatric wards, oncology units), contact our engineering team for application-specific safety documentation: (650) 646-5199.

Our consultation process is structured to deliver a complete specification in 5–10 business days: Day 1–2: Initial call to understand your facility type, size, current HVAC specifications, regulatory compliance requirements, and primary contaminant concerns. Day 3–5: Engineering review of facility documentation (HVAC drawings, existing air quality test data, regulatory compliance reports). Day 6–8: System specification development — filter media selection, housing design, integration approach, CFM calculations. Day 9–10: Written proposal with engineering specifications, compliance documentation strategy, and installation timeline. Contact us to begin: (650) 646-5199 or sales@iodineairsystems.com.

// ASHRAE 241 · EPA · OSHA · CDC · NRC Compliant · Custom Engineered · North America
Protect Your Facility. Start Here.
Custom consultation · Engineering specification · 5–10 business day turnaround · (650) 646-5199 · sales@iodineairsystems.com
// Share & Connect